MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

Catalog Number CXA230005

Device Problem Human-Device Interface Problem (2949)

Patient Problem Rupture (2208)

Event Date 09/22/2023

Event Type  Death  

Manufacturer Narrative

B7: patient medical history includes but is not limited to: pad; ilac artery pseudo aneurysm; osteo myelitis r foot; aaa; hypertension.D10: patient medications include but are not limited to: toprol 50mg q day; plavix 75m q day.D10: as gore was unable to determine which device was involved in the event if any; additional device(s) implanted include: cxa230005/27223239, cxa230005/ 27223240, udi: (b)(4) for both devices the instructions for use (ifu) for the gore® excluder® conformable aaa endoprosthesis states, adverse events that may occur and / or require intervention or additional intraoperative procedure time include, but are not limited to: bleeding, vascular spasm or vascular trauma, dissection, perforation, or ruptures of the aortic vessel and surrounding vasculature, death.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.

Event Description

On an unknown date approximately 20 years ago this patient underwent an open aortic bifurcated repair of the abdominal aorta.On (b)(6) 2023, this patient underwent endovascular treatment for a leak (unknown type) at the anastomosis site.The treatment plan was to place 2 gore® excluder® aortic extender endoprosthesis (cxa23005 x2) (ae's) across the anastomosis and achieve seal.The first ae was deployed at the level of the bifurcation with the second ae deployed at the level of the renal artery with significant overlap of the ae's.Both gore® excluder® aortic extender endoprostheses deployed properly and successfully.When ballooning with a gore® molding & occlusion balloon catheter (mob); we ballooned the overlap zone and at the level of the renal arteries, and a little outside the graft proximally.The patient then experienced a sudden drop in blood pressure.Subsequently an aortic rupture was identified (which appeared to be a tear longitudinally) just outside the proximal ae.The mob was relocated above the level of the renal arteries in an attempt to get some stability of the blood flow and the patient.Two additional gore® excluder® aortic extender components (cxa23005 and cxa26005) were implanted with the second one (cxa26005) placed with unplanned intentional coverage of the lowest renal artery, to try and gain some stability of the rupture site.With no resolution, the physician then decided to implant a gore® excluder® conformable aaa endoprosthesis which was successfully deployed, but did not resolve the situation.All endovascular attempts to stabilize the patient failed and the patient coded on the table.Chest compressions were performed however the patient expired on the table.It was reported that while blood products had been ordered, the patient had not been transfused.The ruptured aorta is believed to have been solely due to overinflation of the mob balloon coupled with use outside the graft.

Manufacturer Narrative

D3: corrected manufacturing site address for site 3007284313 for the following devices: cxa230005/(b)(6), cxa230005/(b)(6), cxa230005/ (b)(6).

• Brand Name: GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS
• Type of Device: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
• Manufacturer (Section D): W. L. GORE & ASSOCIATES, INC.; 32470 n. north valley parkway; phoenix AZ 85085
• Manufacturer (Section G): MEDICAL SILICON VALLEY B/P; 2890 de la cruz blvd.; santa clara CA 95050
• Manufacturer Contact: laura crawford ; 1505 n. fourth street; flagstaff, AZ 86004 ; 9285263030
• MDR Report Key: 17917163
• MDR Text Key: 325443285
• Report Number: 3013164176-2023-01863
• Device Sequence Number: 1
• Product Code: MIH
• UDI-Device Identifier: 00733132650934
• UDI-Public: 00733132650934
• Combination Product (y/n): N
• Reporter Country Code: US
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Company Representative
• Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date: 12/04/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Catalogue Number: CXA230005
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: Not provided
• Initial Date FDA Received: 10/11/2023
• Supplement Dates Manufacturer Received: 09/22/2023
• Supplement Dates FDA Received: 12/04/2023
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 07/16/2023
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Life Threatening; Death
• Patient Age: 82 YR
• Patient Sex: Female
• Patient Weight: 55 KG